NEW YORK, Dec. 10, 2014 /PRNewswire/ -- The biopharmaceutical and vaccine production market is estimated to reach $41 billion in 2014, according to a recent report on the industry from Kalorama Information. The healthcare market research publisher said that existing firms are near capacity with the amount of biologic development. In Kalorama's recent report Biopharmaceutical and Vaccine Production Markets, the firm says that the key driver in biopharmaceutical manufacturing is the sheer number of biologic products in the pipeline.
"It is estimated there are more than 400 biotech drug products and vaccines targeting hundreds of the diseases in the pipeline," said Bruce Carlson, Publisher of Kalorama Information. "Over the next several years, as the number of biologics produced increases, the demand for biologic manufacturing capacity will continue to increase."
The report says that since 2000, the demand for biopharmaceutical contract manufacturing services grew due to several underlying factors, including the growth of the biopharmaceutical drug market, the increase in the number of biopharmaceutical development projects, and the increase use of contract manufacturing organizations by the pharmaceutical and biotechnology industry for the production of their biopharmaceuticals. Biotechnology has created many new therapies and vaccines, including products to treat cancer, diabetes, HIV/AIDS and autoimmune disorders.
Demand continues to increase for biopharmaceutical production using mammalian cell culture and microbial fermentation processes. Capacity utilization for integrated biopharmaceutical manufacturers and large contract manufacturing organizations (CMO) are presently estimated at 81% for microbial fermentation and 71% for mammalian cell culture. This is a change according to the report, the economic downturn and lower approvals rates for new molecular entities dampened the demand for biopharmaceutical contract manufacturing services earlier this decade.
The report, Biopharmaceutical and Vaccine Production Markets (Mammalian Cell Production, Microbial Cell Production Market, Monoclonal Antibody Manufacturing, Other Recombinant Protein Manufacturing, Vaccine Manufacturing, Insulin Manufacturing Market) is available from Kalorama Information. http://www.kaloramainformation.com/Biopharmaceutical-Vaccine-Production-8357580/.
About Kalorama Information -- Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.
Contact:
Bruce Carlson
(212) 807-2622
bcarlson@kaloramainformation.com
www.KaloramaInformation.com
Logo - http://photos.prnewswire.com/prnh/20140801/132634
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/report-demand-surges-for-biologics-production-as-capacity-nears-limit-300004391.html
SOURCE Kalorama Information